{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:51:41Z","timestamp":1791377501198,"version":"4.3.2"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00213-023-06517-1","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T22:02:01Z","timestamp":1702245721000},"page":"1457-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?"],"prefix":"10.1007","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-4081","authenticated-orcid":false,"given":"Haley Maria","family":"Dourron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"6517_CR1","unstructured":"5-MeO-DMT Information & Education. (n.d.). F.I.V.E. https:\/\/five-meo.education\/basic-information\/. Accessed 26 Sept 2023"},{"issue":"8","key":"6517_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archpsyc.1983.01790070074009","volume":"40","author":"HD Abraham","year":"1983","unstructured":"Abraham HD (1983) Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 40(8):884. https:\/\/doi.org\/10.1001\/archpsyc.1983.01790070074009","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"6517_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1212\/wnl.51.1.56","volume":"51","author":"V Acharya","year":"1998","unstructured":"Acharya V, Acharya J, L\u00fcders H (1998) Olfactory epileptic auras. Neurology 51(1):56\u201361. https:\/\/doi.org\/10.1212\/wnl.51.1.56","journal-title":"Neurology"},{"key":"6517_CR4","unstructured":"Acosta-Urquidi, J. (2015). QEEG studies of the acute effects of the visionary tryptamine DMT. Cosmos and History: The Journal of Natural and Social Philosophy, 11(2), Article 2."},{"issue":"4","key":"6517_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/01.NMD.0000061149.26296.DC","volume":"191","author":"N Adachi","year":"2003","unstructured":"Adachi N, Adachi T, Kimura M, Akanuma N, Takekawa Y, Kato M (2003) Demographic and psychological features of d\u00e9j\u00e0 vu experiences in a nonclinical japanese population. J Nerv Ment Dis 191(4):242\u2013247. https:\/\/doi.org\/10.1097\/01.NMD.0000061149.26296.DC","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"6517_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yebeh.2010.02.016","volume":"18","author":"N Adachi","year":"2010","unstructured":"Adachi N, Akanuma N, Ito M, Adachi T, Takekawa Y, Adachi Y, Matsuura M, Kanemoto K, Kato M (2010) Two forms of d\u00e9j\u00e0 vu experiences in patients with epilepsy. Epilepsy Behav 18(3):218\u2013222. https:\/\/doi.org\/10.1016\/j.yebeh.2010.02.016","journal-title":"Epilepsy Behav"},{"issue":"Pt B","key":"6517_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s1054-3589(08)60320-8","volume":"6","author":"U Ahlborg","year":"1968","unstructured":"Ahlborg U, Holmstedt B, Lindgren JE (1968) Fate and metabolism of some hallucinogenic indolealkylamines. Adv Pharmacol 6(Pt B):213\u2013229. https:\/\/doi.org\/10.1016\/s1054-3589(08)60320-8","journal-title":"Adv Pharmacol"},{"key":"6517_CR8","doi-asserted-by":"publisher","unstructured":"Al-Imam, A., Motyka, M. A., Hoffmann, B., Magowska, A., & Michalak, M. (2023). Infoveillance and critical analysis of the systematically reviewed literature on dimethyltryptamine and the \u201cGod molecule.\u201d Pharmaceuticals, 16(6), Article 6. https:\/\/doi.org\/10.3390\/ph16060831","DOI":"10.3390\/ph16060831"},{"key":"6517_CR9","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (Ed.). (2022). Diagnostic and statistical manual of mental disorders: DSM-5-TR (Fifth edition, text revision). American Psychiatric Association Publishing.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"6517_CR10","unstructured":"Antibody. (2016). 5-MeO-DMT - Erowid Exp\u2014\u2019Don\u2019t You Dare Die on Me\u2019. Erowid. https:\/\/erowid.org\/experiences\/exp.php?ID=103843. Accessed 14 June 2023"},{"issue":"2","key":"6517_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-b","volume":"40","author":"R Araneda","year":"1991","unstructured":"Araneda R, Andrade R (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40(2):399\u2013412. https:\/\/doi.org\/10.1016\/0306-4522(91)90128-b","journal-title":"Neuroscience"},{"issue":"6","key":"6517_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.yebeh.2003.09.009","volume":"4","author":"B \u00c5sheim Hansen","year":"2003","unstructured":"\u00c5sheim Hansen B, Brodtkorb E (2003) Partial epilepsy with \u201cecstatic\u201d seizures. Epilepsy Behav 4(6):667\u2013673. https:\/\/doi.org\/10.1016\/j.yebeh.2003.09.009","journal-title":"Epilepsy Behav"},{"issue":"4","key":"6517_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","volume":"100","author":"G Bagdy","year":"2007","unstructured":"Bagdy G, Kecskemeti V, Riba P, Jakus R (2007) Serotonin and epilepsy. J Neurochem 100(4):857\u2013873. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04277.x","journal-title":"J Neurochem"},{"key":"6517_CR14","unstructured":"Ball, M., Nation, H. L., Leszczynka, M., Alvarius, J. D., Martin, O., Wueschner, V., Brierre, J., Karuna, I. M., & Razam, R. (2022). Facilitating 5-MeO-DMT: An anthology of approaches to serving the god molecule. Kyandara Publishing."},{"key":"6517_CR15","doi-asserted-by":"publisher","unstructured":"Bancaud, J., Brunet-Bourgin, F., Chauvel, P., Halgren, E., & This paper is dedicated to the memory of Jean Bancaud. (1994). Anatomical origin of d\u00e9j\u00e0 vu and vivid \u2018memories\u2019 in human temporal lobe epilepsy. Brain, 117(1), 71\u201390.https:\/\/doi.org\/10.1093\/brain\/117.1.71","DOI":"10.1093\/brain\/117.1.71"},{"issue":"12","key":"6517_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/0269881116678781","volume":"30","author":"FS Barrett","year":"2016","unstructured":"Barrett FS, Bradstreet MP, Leoutsakos J-MS, Johnson MW, Griffiths RR (2016) The challenging experience questionnaire: Characterization of challenging experiences with psilocybin mushrooms. J Psychopharmacol (Oxford, England) 30(12):1279\u20131295. https:\/\/doi.org\/10.1177\/0269881116678781","journal-title":"J Psychopharmacol (Oxford, England)"},{"issue":"11","key":"6517_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/0269881115609019","volume":"29","author":"FS Barrett","year":"2015","unstructured":"Barrett FS, Johnson MW, Griffiths RR (2015) Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. J Psychopharmacol (Oxford, England) 29(11):1182\u20131190. https:\/\/doi.org\/10.1177\/0269881115609019","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"6517_CR18","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3389\/fpsyg.2018.02459","volume":"9","author":"J Barsuglia","year":"2018","unstructured":"Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman A-M, Peterson K, Polanco M, Grant R, Griffiths RR (2018) Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. Front Psychol 9:2459. https:\/\/doi.org\/10.3389\/fpsyg.2018.02459","journal-title":"Front Psychol"},{"key":"6517_CR19","unstructured":"Bateman, D. N. (Ed.). (2014). Toxicology. Oxford University Press."},{"issue":"5","key":"6517_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.seizure.2005.04.004","volume":"14","author":"CR Baumann","year":"2005","unstructured":"Baumann CR, Novikov VPI, Regard M, Siegel AM (2005) Did Fyodor mikhailovich dostoevsky suffer from mesial temporal lobe epilepsy? Seizure 14(5):324\u2013330. https:\/\/doi.org\/10.1016\/j.seizure.2005.04.004","journal-title":"Seizure"},{"issue":"4","key":"6517_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/cpt.2487","volume":"111","author":"AM Becker","year":"2022","unstructured":"Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Gr\u00fcnblatt E, Liechti ME (2022) Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Clin Pharmacol Ther 111(4):886\u2013895. https:\/\/doi.org\/10.1002\/cpt.2487","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"6517_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1523\/JNEUROSCI.2830-16.2016","volume":"37","author":"V Beliveau","year":"2017","unstructured":"Beliveau V, Ganz M, Feng L, Ozenne B, H\u00f8jgaard L, Fisher PM, Svarer C, Greve DN, Knudsen GM (2017) A high-resolution in vivo atlas of the human brain\u2019s serotonin system. J Neurosci 37(1):120\u2013128. https:\/\/doi.org\/10.1523\/JNEUROSCI.2830-16.2016","journal-title":"J Neurosci"},{"issue":"2","key":"6517_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","volume":"53","author":"L Bertilsson","year":"2002","unstructured":"Bertilsson L, Dahl M-L, Dal\u00e9n P, Al-Shurbaji A (2002) Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 53(2):111\u2013122. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.01548.x","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 2","key":"6517_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1528-1167.2007.01068.x","volume":"48","author":"E Bertram","year":"2007","unstructured":"Bertram E (2007) The relevance of kindling for human epilepsy. Epilepsia 48(Suppl 2):65\u201374. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01068.x","journal-title":"Epilepsia"},{"key":"6517_CR25","doi-asserted-by":"publisher","unstructured":"Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., Simeons, F. R. C., Stojanovski, L., Prat, A., Seidah, N. G., Constam, D. B., Bickerton, G. R., Read, K. D., Wetsel, W. C., Gilbert, I. H., \u2026 Hopkins, A. L. (2012). Automated design of ligands to polypharmacological profiles. Nature, 492(7428), 215\u2013220. https:\/\/doi.org\/10.1038\/nature11691","DOI":"10.1038\/nature11691"},{"key":"6517_CR26","doi-asserted-by":"crossref","unstructured":"Bhatti, M., Dorriz, P., & Mehndiratta, P. (2017). Impact of psychotropic drugs on seizure threshold (P6.311). Neurology, 88(16 Supplement). https:\/\/n.neurology.org\/content\/88\/16_Supplement\/P6.311","DOI":"10.1212\/WNL.88.16_supplement.P6.311"},{"key":"6517_CR27","doi-asserted-by":"publisher","unstructured":"Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014). Chapter 22\u2014Psychopharmacology for social anxiety disorder. In S. G. Hofmann & P. M. DiBartolo (Eds.), Social anxiety (Third Edition) (pp. 625\u2013659). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-12-394427-6.00022-4","DOI":"10.1016\/B978-0-12-394427-6.00022-4"},{"key":"6517_CR28","doi-asserted-by":"publisher","first-page":"1214969","DOI":"10.3389\/fneur.2023.1214969","volume":"14","author":"BN Blond","year":"2023","unstructured":"Blond BN, Schindler EAD (2023) Case report: Psychedelic-induced seizures captured by intracranial electrocorticography. Front Neurol 14:1214969. https:\/\/doi.org\/10.3389\/fneur.2023.1214969","journal-title":"Front Neurol"},{"key":"6517_CR29","doi-asserted-by":"publisher","first-page":"108219","DOI":"10.1016\/j.yebeh.2021.108219","volume":"122","author":"I Bone","year":"2021","unstructured":"Bone I, Dein S (2021) Religion, spirituality, and epilepsy. Epilepsy & Behavior: E&B 122:108219. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108219","journal-title":"Epilepsy & Behavior: E&B"},{"key":"6517_CR30","unstructured":"Bowers J (2015) Personal Story: My 5-MeO-DMT Experience. Reset.Me. https:\/\/reset.me\/personal-story\/personal-story-my-5-meo-dmt-experience\/. Accessed 7 Oct 2022"},{"issue":"2","key":"6517_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/02791072.2019.1598603","volume":"51","author":"TK Brown","year":"2019","unstructured":"Brown TK, Noller GE, Denenberg JO (2019) Ibogaine and subjective experience: Transformative states and psychopharmacotherapy in the treatment of opioid use disorder. J Psychoactive Drugs 51(2):155\u2013165. https:\/\/doi.org\/10.1080\/02791072.2019.1598603","journal-title":"J Psychoactive Drugs"},{"key":"6517_CR32","unstructured":"Burbea, R. (2020). Practising the Jh\u0101nas. Dharma Seed. https:\/\/dharmaseed.org\/retreats\/4496\/"},{"key":"6517_CR33","doi-asserted-by":"publisher","first-page":"109354","DOI":"10.1016\/j.yebeh.2023.109354","volume":"145","author":"L Cai","year":"2023","unstructured":"Cai L, Xu Z, Luo H, He Q, Diao L, Gui X, Wei L (2023) The association between 5-HT1A binding and temporal lobe epilepsy: A meta-analysis of molecular imaging studies. Epilepsy Behav 145:109354. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109354","journal-title":"Epilepsy Behav"},{"issue":"7","key":"6517_CR34","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Benson CJ, Dunlap LE, Olson DE (2018) Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci 9(7):1582\u20131590. https:\/\/doi.org\/10.1021\/acschemneuro.8b00134","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"6517_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/acn3.51607","volume":"9","author":"Q Cao","year":"2022","unstructured":"Cao Q, Cui T, Wang Q, Li Z, Fan S, Xiao Z, Pan S, Zhou Q, Lu Z, Shao X (2022) The localization and lateralization of fear aura and its surgical prognostic value in patients with focal epilepsy. Ann Clin Transl Neurol 9(8):1116\u20131124. https:\/\/doi.org\/10.1002\/acn3.51607","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"6517_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","volume":"30","author":"TM Carbonaro","year":"2016","unstructured":"Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England) 30(12):1268\u20131278. https:\/\/doi.org\/10.1177\/0269881116662634","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"2","key":"6517_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/15294145.2007.10773557","volume":"9","author":"R Carhart-Harris","year":"2007","unstructured":"Carhart-Harris R (2007) Waves of the unconscious: The neurophysiology of Dreamlike phenomena and its implications for the psychodynamic model of the mind. Neuropsychoanalysis 9(2):183\u2013211. https:\/\/doi.org\/10.1080\/15294145.2007.10773557","journal-title":"Neuropsychoanalysis"},{"issue":"9","key":"6517_CR38","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"R Carhart-Harris","year":"2017","unstructured":"Carhart-Harris R, Nutt D (2017) Serotonin and brain function: A tale of two receptors. J Psychopharmacol 31(9):1091\u20131120. https:\/\/doi.org\/10.1177\/0269881117725915","journal-title":"J Psychopharmacol"},{"key":"6517_CR39","doi-asserted-by":"publisher","unstructured":"Carli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006). Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology, 31(4), Article 4. https:\/\/doi.org\/10.1038\/sj.npp.1300893","DOI":"10.1038\/sj.npp.1300893"},{"issue":"3","key":"6517_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/WNN.0b013e318230b1db","volume":"24","author":"E Carrazana","year":"2011","unstructured":"Carrazana E, Cheng J (2011) St Theresa\u2019s dart and a case of religious ecstatic epilepsy. Cogn Behav Neurol 24(3):152\u2013155. https:\/\/doi.org\/10.1097\/WNN.0b013e318230b1db","journal-title":"Cogn Behav Neurol"},{"issue":"9","key":"6517_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","volume":"27","author":"P Celada","year":"2013","unstructured":"Celada P, Bortolozzi A, Artigas F (2013) Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: Rationale and current status of research. CNS Drugs 27(9):703\u2013716. https:\/\/doi.org\/10.1007\/s40263-013-0071-0","journal-title":"CNS Drugs"},{"issue":"2","key":"6517_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1528-1157.2003.25902.x","volume":"44","author":"C Chen","year":"2003","unstructured":"Chen C, Shih Y-H, Yen D-J, Lirng J-F, Guo Y-C, Yu H-Y, Yiu C-H (2003) Olfactory auras in patients with temporal lobe epilepsy. Epilepsia 44(2):257\u2013260. https:\/\/doi.org\/10.1046\/j.1528-1157.2003.25902.x","journal-title":"Epilepsia"},{"key":"6517_CR43","doi-asserted-by":"publisher","unstructured":"Chen, M., Yang, X., Liu, C., Li, J., Wang, X., Yang, C., Hu, X., Li, J., Zhao, J., Li, X., Xu, Y., & Liu, S. (2021). Comparative efficacy and cognitive function of magnetic seizure therapy vs. electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. Translational Psychiatry, 11(1), 437. https:\/\/doi.org\/10.1038\/s41398-021-01560-y","DOI":"10.1038\/s41398-021-01560-y"},{"issue":"6","key":"6517_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/practneurol-2019-002341","volume":"21","author":"FA Chowdhury","year":"2021","unstructured":"Chowdhury FA, Silva R, Whatley B, Walker MC (2021) Localisation in focal epilepsy: A practical guide. Pract Neurol 21(6):481\u2013491. https:\/\/doi.org\/10.1136\/practneurol-2019-002341","journal-title":"Pract Neurol"},{"issue":"1","key":"6517_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1734-1140(11)70394-2","volume":"63","author":"M Chro\u015bci\u0144ska-Krawczyk","year":"2011","unstructured":"Chro\u015bci\u0144ska-Krawczyk M, Jargie\u0142\u0142o-Baszak M, Wa\u0142ek M, Tylus B, Czuczwar SJ (2011) Caffeine and the anticonvulsant potency of antiepileptic drugs: Experimental and clinical data. Pharmacol Rep 63(1):12\u201318. https:\/\/doi.org\/10.1016\/S1734-1140(11)70394-2","journal-title":"Pharmacol Rep"},{"key":"6517_CR46","unstructured":"Clark R (2022a)\u00a05-MeO-DMT | DanceSafe. https:\/\/dancesafe.org\/5-meo-dmt\/. Accessed 2 Oct 2023"},{"key":"6517_CR47","unstructured":"Clark R (2022b)\u00a0DMT | DanceSafe. https:\/\/dancesafe.org\/dmt\/. Accessed 2 Oct 2023"},{"key":"6517_CR48","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.yebeh.2021.108373","volume":"125","author":"AM Cleary","year":"2021","unstructured":"Cleary AM, Neisser J, McMahan T, Parsons TD, Alwaki A, Okada N, Vosoughi A, Kheder A, Drane DL, Pedersen NP (2021) Subjective distinguishability of seizure and non-seizure d\u00e9j\u00e0 vu: A case report, brief literature review, and research prospects. Epilepsy Behav 125:108373. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108373","journal-title":"Epilepsy Behav"},{"key":"6517_CR49","doi-asserted-by":"publisher","first-page":"720579","DOI":"10.3389\/fpsyg.2021.720579","volume":"12","author":"JS Corneille","year":"2021","unstructured":"Corneille JS, Luke D (2021) Spontaneous spiritual awakenings: phenomenology, altered states, individual differences, and well-being. Front Psychol 12:720579. https:\/\/doi.org\/10.3389\/fpsyg.2021.720579","journal-title":"Front Psychol"},{"key":"6517_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuropharm.2018.01.005","volume":"142","author":"E Dakwar","year":"2018","unstructured":"Dakwar E, Nunes E, Hart C, Hu M, Foltin R, Levin F (2018) A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study. Neuropharmacology 142:270\u2013276. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.005","journal-title":"Neuropharmacology"},{"issue":"4","key":"6517_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","volume":"36","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA (1990) Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36(4):901\u2013906. https:\/\/doi.org\/10.1016\/0091-3057(90)90098-3","journal-title":"Pharmacol Biochem Behav"},{"key":"6517_CR52","unstructured":"Davis, A. K. (2019). The potential for healing and harm with 5-MeO-DMT. Horizons 2019. https:\/\/www.youtube.com\/watch?v=PGuFmqnX_Ww"},{"issue":"7","key":"6517_CR53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/0269881118769063","volume":"32","author":"AK Davis","year":"2018","unstructured":"Davis AK, Barsuglia JP, Lancelotta R, Grant RM, Renn E (2018) The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. J Psychopharmacol (Oxford, England) 32(7):779\u2013792. https:\/\/doi.org\/10.1177\/0269881118769063","journal-title":"J Psychopharmacol (Oxford, England)"},{"issue":"9","key":"6517_CR54","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1177\/0269881120916143","volume":"34","author":"AK Davis","year":"2020","unstructured":"Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR (2020) Survey of entity encounter experiences occasioned by inhaled N, N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. J Psychopharmacol 34(9):1008\u20131020. https:\/\/doi.org\/10.1177\/0269881120916143","journal-title":"J Psychopharmacol"},{"issue":"2","key":"6517_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/00952990.2018.1545024","volume":"45","author":"AK Davis","year":"2019","unstructured":"Davis AK, So S, Lancelotta R, Barsuglia JP, Griffiths RR (2019) 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Am J Drug Alcohol Abuse 45(2):161\u2013169. https:\/\/doi.org\/10.1080\/00952990.2018.1545024","journal-title":"Am J Drug Alcohol Abuse"},{"key":"6517_CR56","unstructured":"de Greef, K. (2022, March 21). The pied piper of psychedelic toads. The New Yorker. https:\/\/www.newyorker.com\/magazine\/2022\/03\/28\/the-pied-piper-of-psychedelic-toads"},{"issue":"16","key":"6517_CR57","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","volume":"13","author":"M de la Fuente Revenga","year":"2022","unstructured":"de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonz\u00e1lez-Maeso J (2022) Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT2A receptor agonists in mice. ACS Chem Neurosci 13(16):2436\u20132448. https:\/\/doi.org\/10.1021\/acschemneuro.2c00170","journal-title":"ACS Chem Neurosci"},{"key":"6517_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yebeh.2017.12.023","volume":"80","author":"H\u00d6 Dede","year":"2018","unstructured":"Dede H\u00d6, Bebek N, G\u00fcrses C, Baysal-K\u0131ra\u00e7 L, Baykan B, G\u00f6kyi\u011fit A (2018) Genital automatisms: Reappraisal of a remarkable but ignored symptom of focal seizures. Epilepsy Behav 80:84\u201389. https:\/\/doi.org\/10.1016\/j.yebeh.2017.12.023","journal-title":"Epilepsy Behav"},{"key":"6517_CR59","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnhum.2019.00178","volume":"13","author":"P Dennison","year":"2019","unstructured":"Dennison P (2019) The human default consciousness and its disruption: Insights from an EEG study of buddhist jh\u0101na meditation. Front Hum Neurosci 13:178. https:\/\/doi.org\/10.3389\/fnhum.2019.00178","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"6517_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0896-6974(05)80069-6","volume":"4","author":"O Devinsky","year":"1991","unstructured":"Devinsky O, Feldmann E, Bromfield E, Emoto S, Raubertas R (1991) Structured interview for partial seizures: Clinical phenomenology and diagnosis. Journal of Epilepsy 4(2):107\u2013116. https:\/\/doi.org\/10.1016\/S0896-6974(05)80069-6","journal-title":"Journal of Epilepsy"},{"issue":"4","key":"6517_CR61","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.yebeh.2007.11.011","volume":"12","author":"O Devinsky","year":"2008","unstructured":"Devinsky O, Lai G (2008) Spirituality and religion in epilepsy. Epilepsy Behav 12(4):636\u2013643. https:\/\/doi.org\/10.1016\/j.yebeh.2007.11.011","journal-title":"Epilepsy Behav"},{"issue":"1","key":"6517_CR62","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","volume":"4","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Vezzani A, O\u2019Brien TJ, Jette N, Scheffer IE, de Curtis M, Perucca P (2018) Epilepsy. Nat Rev Dis Primers 4(1):18024. https:\/\/doi.org\/10.1038\/nrdp.2018.24","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"6517_CR63","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1093\/brain\/awn220","volume":"131","author":"A Didelot","year":"2008","unstructured":"Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Maugui\u00e8re F (2008) PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 131(10):2751\u20132764. https:\/\/doi.org\/10.1093\/brain\/awn220","journal-title":"Brain"},{"issue":"2","key":"6517_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1399-5618.2012.00997.x","volume":"14","author":"B Dierckx","year":"2012","unstructured":"Dierckx B, Heijnen WT, van den Broek WW, Birkenh\u00e4ger TK (2012) Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis. Bipolar Disord 14(2):146\u2013150. https:\/\/doi.org\/10.1111\/j.1399-5618.2012.00997.x","journal-title":"Bipolar Disord"},{"issue":"4","key":"6517_CR65","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","volume":"219","author":"RG dos Santos","year":"2012","unstructured":"dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomded\u00e9u JF, Homs R, Barbanoj MJ, Riba J (2012) Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology 219(4):1039\u20131053. https:\/\/doi.org\/10.1007\/s00213-011-2434-x","journal-title":"Psychopharmacology"},{"issue":"4","key":"6517_CR66","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1124\/pharmrev.121.000514","volume":"74","author":"HM Dourron","year":"2022","unstructured":"Dourron HM, Strauss C, Hendricks PS (2022) Self-entropic broadening theory: Toward a new understanding of self and behavior change informed by psychedelics and psychosis. Pharmacol Rev 74(4):982\u20131027. https:\/\/doi.org\/10.1124\/pharmrev.121.000514","journal-title":"Pharmacol Rev"},{"issue":"4","key":"6517_CR67","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/09658210444000025","volume":"12","author":"A Ehlers","year":"2004","unstructured":"Ehlers A, Hackmann A, Michael T (2004) Intrusive re-experiencing in post-traumatic stress disorder: Phenomenology, theory, and therapy. Memory 12(4):403\u2013415. https:\/\/doi.org\/10.1080\/09658210444000025","journal-title":"Memory"},{"key":"6517_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.scog.2017.05.002","volume":"9","author":"MA Erickson","year":"2017","unstructured":"Erickson MA, Albrecht M, Ruffle A, Fleming L, Corlett P, Gold J (2017) No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach. Schizophr Res: Cogn 9:13\u201317. https:\/\/doi.org\/10.1016\/j.scog.2017.05.002","journal-title":"Schizophr Res: Cogn"},{"issue":"3","key":"6517_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/02698811211050543","volume":"36","author":"AO Ermakova","year":"2022","unstructured":"Ermakova AO, Dunbar F, Rucker J, Johnson MW (2022) A narrative synthesis of research with 5-MeO-DMT. J Psychopharmacol 36(3):273\u2013294. https:\/\/doi.org\/10.1177\/02698811211050543","journal-title":"J Psychopharmacol"},{"key":"6517_CR70","unstructured":"Erowid (2015a)\u00a05-MeO-DMT: Effects. https:\/\/erowid.org\/chemicals\/5meo_dmt\/5meo_dmt_effects.shtml. Accessed 26 Sept 2023"},{"key":"6517_CR71","unstructured":"Erowid (2015b)\u00a0DMT: Effects. https:\/\/erowid.org\/chemicals\/dmt\/dmt_effects.shtml. Accessed 26 Sept 2023"},{"issue":"7","key":"6517_CR72","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza RT, Kellner CH (2022) Electroconvulsive therapy. N Engl J Med 386(7):667\u2013672. https:\/\/doi.org\/10.1056\/NEJMra2034954","journal-title":"N Engl J Med"},{"issue":"5","key":"6517_CR73","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/archneur.58.5.771","volume":"58","author":"M Feichtinger","year":"2001","unstructured":"Feichtinger M, Pauli E, Sch\u00e4fer I, Eberhardt KW, Tomandl B, Huk J, Stefan H (2001) Ictal fear in temporal lobe epilepsy: Surgical outcome and focal hippocampal changes revealed by proton magnetic resonance spectroscopy imaging. Arch Neurol 58(5):771\u2013777. https:\/\/doi.org\/10.1001\/archneur.58.5.771","journal-title":"Arch Neurol"},{"issue":"3","key":"6517_CR74","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1176\/jnp.9.3.420","volume":"9","author":"I Fried","year":"1997","unstructured":"Fried I (1997) Auras and experiential responses arising in the temporal lobe. J Neuropsychiatry Clin Neurosci 9(3):420\u2013428. https:\/\/doi.org\/10.1176\/jnp.9.3.420","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6517_CR75","unstructured":"G Lerner, A., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: A clinical-oriented concise review. The Israel Journal of Psychiatry and Related Sciences, 51(4), 296\u2013301."},{"key":"6517_CR76","unstructured":"Gallimore, A. R. (2022). Reality switch technologies: Psychedelics as tools for the discovery and exploration of new worlds (First edition). Strange Worlds Press."},{"key":"6517_CR77","doi-asserted-by":"publisher","first-page":"849899","DOI":"10.3389\/fnhum.2022.849899","volume":"16","author":"D Garg","year":"2022","unstructured":"Garg D, Charlesworth L, Shukla G (2022) Sleep and temporal lobe epilepsy \u2013 associations, mechanisms and treatment implications. Front Hum Neurosci 16:849899. https:\/\/doi.org\/10.3389\/fnhum.2022.849899","journal-title":"Front Hum Neurosci"},{"key":"6517_CR78","doi-asserted-by":"publisher","first-page":"102997","DOI":"10.1016\/j.drugpo.2020.102997","volume":"87","author":"L Gashi","year":"2021","unstructured":"Gashi L, Sandberg S, Pedersen W (2021) Making \u201cbad trips\u201d good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy 87:102997. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102997","journal-title":"International Journal of Drug Policy"},{"issue":"1\u20132","key":"6517_CR79","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0006-8993(98)00801-4","volume":"807","author":"K Gerber","year":"1998","unstructured":"Gerber K, Filakovszky J, Halasz P, Bagdy G (1998) The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 807(1\u20132):243\u2013245. https:\/\/doi.org\/10.1016\/S0006-8993(98)00801-4","journal-title":"Brain Res"},{"issue":"1","key":"6517_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1152\/ajplegacy.1962.203.1.167","volume":"203","author":"PK Gessner","year":"1962","unstructured":"Gessner PK, Page IH (1962) Behavioral effects of 5-methoxy-N:N-dimethyltryptamine, other tryptamines, and LSD. Am J Physiol-Legacy Content 203(1):167\u2013172. https:\/\/doi.org\/10.1152\/ajplegacy.1962.203.1.167","journal-title":"Am J Physiol-Legacy Content"},{"issue":"2","key":"6517_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","volume":"232","author":"MH Gharedaghi","year":"2014","unstructured":"Gharedaghi MH, Seyedabadi M, Ghia J-E, Dehpour AR, Rahimian R (2014) The role of different serotonin receptor subtypes in seizure susceptibility. Exp Brain Res 232(2):347\u2013367. https:\/\/doi.org\/10.1007\/s00221-013-3757-0","journal-title":"Exp Brain Res"},{"issue":"3","key":"6517_CR82","first-page":"355","volume":"11","author":"JC Gillin","year":"1976","unstructured":"Gillin JC, Tinklenberg J, Stoff DM, Stillman R, Shortlidge JS, Wyatt RJ (1976) 5-methoxy-N, N-dimethyltryptamine: Behavioral and toxicological effects in animals. Biol Psychiatry 11(3):355\u2013358","journal-title":"Biol Psychiatry"},{"issue":"11","key":"6517_CR83","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.clinph.2013.04.342","volume":"124","author":"FS Giorgi","year":"2013","unstructured":"Giorgi FS, Perini D, Maestri M, Guida M, Pizzanelli C, Caserta A, Iudice A, Bonanni E (2013) Usefulness of a simple sleep-deprived EEG protocol for epilepsy diagnosis in de novo subjects. Clin Neurophysiol 124(11):2101\u20132107. https:\/\/doi.org\/10.1016\/j.clinph.2013.04.342","journal-title":"Clin Neurophysiol"},{"key":"6517_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuro.2022.01.002","volume":"89","author":"ME Gonz\u00e1lez-Trujano","year":"2022","unstructured":"Gonz\u00e1lez-Trujano ME, Krengel F, Reyes-Chilpa R, Villasana-Salazar B, Gonz\u00e1lez-G\u00f3mez JD, Santos-Valencia F, Urbina-Trejo E, Mart\u00ednez A, Mart\u00ednez-Vargas D (2022) Tabernaemontana arborea and ibogaine induce paroxysmal EEG activity in freely moving mice: Involvement of serotonin 5-HT1A receptors. Neurotoxicology 89:79\u201391. https:\/\/doi.org\/10.1016\/j.neuro.2022.01.002","journal-title":"Neurotoxicology"},{"key":"6517_CR85","doi-asserted-by":"publisher","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, P\u00e1len\u00ed\u010dek T, Redjep O, Repantis D,\u00a0\u2026, Malievskaia E (2023) Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. Journal of Affective Disorders 327:120\u2013127. https:\/\/doi.org\/10.1016\/j.jad.2023.01.108","DOI":"10.1016\/j.jad.2023.01.108"},{"issue":"6","key":"6517_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2005-916185","volume":"38","author":"E Gouzoulis-Mayfrank","year":"2005","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar K-A (2005) Psychological effects of (S)-Ketamine and N, N-Dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38(6):301\u2013311. https:\/\/doi.org\/10.1055\/s-2005-916185","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"6517_CR87","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1476-5381.1971.tb07222.x","volume":"43","author":"DG Grahame-Smith","year":"1971","unstructured":"Grahame-Smith DG (1971) Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l-tryptophan or 5-methoxy-N, N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor. Br J Pharmacol 43(4):856\u2013864. https:\/\/doi.org\/10.1111\/j.1476-5381.1971.tb07222.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"6517_CR88","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/2153599X.2014.895775","volume":"5","author":"B Greyson","year":"2015","unstructured":"Greyson B, Broshek DK, Derr LL, Fountain NB (2015) Mystical experiences associated with seizures. Relig Brain Behav 5(3):182\u2013196. https:\/\/doi.org\/10.1080\/2153599X.2014.895775","journal-title":"Relig Brain Behav"},{"key":"6517_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnbeh.2016.00021","volume":"10","author":"M Gschwind","year":"2016","unstructured":"Gschwind M, Picard F (2016) Ecstatic epileptic seizures: A glimpse into the multiple roles of the insula. Front Behav Neurosci 10:21. https:\/\/doi.org\/10.3389\/fnbeh.2016.00021","journal-title":"Front Behav Neurosci"},{"issue":"11","key":"6517_CR90","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/0269881110388326","volume":"25","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011) Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol 25(11):1548\u20131561. https:\/\/doi.org\/10.1177\/0269881110388326","journal-title":"J Psychopharmacol"},{"issue":"4","key":"6517_CR91","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00213-011-2616-6","volume":"221","author":"AL Halberstadt","year":"2012","unstructured":"Halberstadt AL, Nichols DE, Geyer MA (2012) Behavioral effects of \u03b1, \u03b1, \u03b2, \u03b2-tetradeutero-5-MeO-DMT in rats: Comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology 221(4):709\u2013718. https:\/\/doi.org\/10.1007\/s00213-011-2616-6","journal-title":"Psychopharmacology"},{"key":"6517_CR92","unstructured":"Handsome. (2009, July 18). 5-MeO-DMT - Erowid Exp\u2014\u2019Convulsions, seizures, vomiting\u2019. Erowid. https:\/\/erowid.org\/experiences\/exp.php?ID=76059"},{"key":"6517_CR93","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.seizure.2018.07.008","volume":"60","author":"E Hartl","year":"2018","unstructured":"Hartl E, Knoche T, Choupina HMP, R\u00e9mi J, Vollmar C, Cunha JPS, Noachtar S (2018) Quantitative and qualitative analysis of ictal vocalization in focal epilepsy syndromes. Seizure 60:178\u2013183. https:\/\/doi.org\/10.1016\/j.seizure.2018.07.008","journal-title":"Seizure"},{"issue":"3","key":"6517_CR94","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13181-016-0593-1","volume":"13","author":"CW Heise","year":"2017","unstructured":"Heise CW, Brooks DE (2017) Ayahuasca exposure: Descriptive analysis of calls to US poison control centers from 2005 to 2015. J Med Toxicol 13(3):245\u2013248. https:\/\/doi.org\/10.1007\/s13181-016-0593-1","journal-title":"J Med Toxicol"},{"issue":"5","key":"6517_CR95","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2045125312451270","volume":"2","author":"L Hermle","year":"2012","unstructured":"Hermle L, Simon M, Ruchsow M, Geppert M (2012) Hallucinogen-persisting perception disorder. Ther Adv Psychopharmacol 2(5):199\u2013205. https:\/\/doi.org\/10.1177\/2045125312451270","journal-title":"Ther Adv Psychopharmacol"},{"issue":"23","key":"6517_CR96","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM198606053142320","volume":"314","author":"M Hitt","year":"1986","unstructured":"Hitt M, Ettinger DD (1986) Toad toxicity. N Engl J Med 314(23):1517\u20131518","journal-title":"N Engl J Med"},{"issue":"1","key":"6517_CR97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/jnnp.2005.062554","volume":"77","author":"RE Hogan","year":"2006","unstructured":"Hogan RE, Rao VK (2006) Hemifacial motor and crying seizures of temporal lobe onset: Case report and review of electro-clinical localisation. J Neurol Neurosurg Psychiatry 77(1):107\u2013110. https:\/\/doi.org\/10.1136\/jnnp.2005.062554","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6517_CR98","doi-asserted-by":"publisher","unstructured":"Holze, F., Ley, L., M\u00fcller, F., Becker, A. M., Straumann, I., Vizeli, P., Kuehne, S. S., Roder, M. A., Duthaler, U., Kolaczynska, K. E., Varghese, N., Eckert, A., & Liechti, M. E. (2022). Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 47(6), Article 6. https:\/\/doi.org\/10.1038\/s41386-022-01297-2","DOI":"10.1038\/s41386-022-01297-2"},{"key":"6517_CR99","doi-asserted-by":"publisher","unstructured":"Holze, F., Vizeli, P., M\u00fcller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology, 45(3), 462\u2013471. https:\/\/doi.org\/10.1038\/s41386-019-0569-3","DOI":"10.1038\/s41386-019-0569-3"},{"key":"6517_CR100","doi-asserted-by":"publisher","first-page":"912697","DOI":"10.3389\/fpsyt.2022.912697","volume":"13","author":"J Hopp","year":"2022","unstructured":"Hopp J, Pahlavan A, Richert M, Grimes K, Turlington K, Cassady M, Kvarta MD, Thompson SM (2022) Peri-ictal changes in depression and anxiety in persons with epileptic and non-epileptic seizures. Front Psych 13:912697. https:\/\/doi.org\/10.3389\/fpsyt.2022.912697","journal-title":"Front Psych"},{"issue":"6","key":"6517_CR101","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/j.1528-1167.2008.01936.x","volume":"50","author":"RA Horvath","year":"2009","unstructured":"Horvath RA, Fogarasi A, Schulz R, Perlaki G, Kalmar Z, T\u00f3th V, Kov\u00e1cs N, Ebner A, Janszky J (2009) Ictal vocalizations occur more often in temporal lobe epilepsy with dominant (left-sided) epileptogenic zone. Epilepsia 50(6):1542\u20131546. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01936.x","journal-title":"Epilepsia"},{"issue":"2","key":"6517_CR102","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/brain\/11.2.179","volume":"11","author":"J Hughlings-Jackson","year":"1888","unstructured":"Hughlings-Jackson J (1888) On a particular variety of epilepsy (\u201cIntellectual aura\u201d), one case with symptoms of organic brain disease. Brain 11(2):179\u2013207. https:\/\/doi.org\/10.1093\/brain\/11.2.179","journal-title":"Brain"},{"issue":"4","key":"6517_CR103","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1176\/jnp.2006.18.4.436","volume":"18","author":"RA Hurley","year":"2006","unstructured":"Hurley RA, Fisher R, Taber KH (2006) Sudden onset panic: Epileptic aura or panic disorder? J Neuropsychiatry Clin Neurosci 18(4):436\u2013443. https:\/\/doi.org\/10.1176\/jnp.2006.18.4.436","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"6517_CR104","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4088\/jcp.v65n0406","volume":"65","author":"MM Husain","year":"2004","unstructured":"Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O\u2019Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH (2004) Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. J Clin Psychiatry 65(4):485\u2013491. https:\/\/doi.org\/10.4088\/jcp.v65n0406","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"6517_CR105","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1059-1311(03)00192-4","volume":"13","author":"J Janszky","year":"2004","unstructured":"Janszky J, Schulz R, Ebner A (2004) Simple partial seizures (isolated auras) in medial temporal lobe epilepsy. Seizure 13(4):247\u2013249. https:\/\/doi.org\/10.1016\/S1059-1311(03)00192-4","journal-title":"Seizure"},{"issue":"3","key":"6517_CR106","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.mehy.2004.09.012","volume":"64","author":"H Jaseja","year":"2005","unstructured":"Jaseja H (2005) Meditation may predispose to epilepsy: An insight into the alteration in brain environment induced by meditation. Med Hypotheses 64(3):464\u2013467. https:\/\/doi.org\/10.1016\/j.mehy.2004.09.012","journal-title":"Med Hypotheses"},{"issue":"1","key":"6517_CR107","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yebeh.2009.10.022","volume":"17","author":"H Jaseja","year":"2010","unstructured":"Jaseja H (2010) Potential role of self-induced EEG fast oscillations in predisposition to seizures in meditators. Epilepsy Behav 17(1):124\u2013125. https:\/\/doi.org\/10.1016\/j.yebeh.2009.10.022","journal-title":"Epilepsy Behav"},{"key":"6517_CR108","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","volume":"197","author":"MW Johnson","year":"2019","unstructured":"Johnson MW, Hendricks PS, Barrett FS, Griffiths RR (2019) Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacol Ther 197:83\u2013102. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.11.010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6517_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2010.03.006","volume":"18","author":"BS Kasper","year":"2010","unstructured":"Kasper BS, Kasper EM, Pauli E, Stefan H (2010) Phenomenology of hallucinations, illusions, and delusions as part of seizure semiology. Epilepsy Behav 18(1):13\u201323. https:\/\/doi.org\/10.1016\/j.yebeh.2010.03.006","journal-title":"Epilepsy Behav"},{"issue":"7","key":"6517_CR110","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1059-1311(03)00048-7","volume":"12","author":"KR Kaufman","year":"2003","unstructured":"Kaufman KR, Sachdeo RC (2003) Caffeinated beverages and decreased seizure control. Seizure 12(7):519\u2013521. https:\/\/doi.org\/10.1016\/S1059-1311(03)00048-7","journal-title":"Seizure"},{"issue":"3","key":"6517_CR111","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0091-3057(94)90175-9","volume":"47","author":"K Kawanishi","year":"1994","unstructured":"Kawanishi K, Eguchi N, Hayashi T, Hashimoto Y (1994) Relationship between occurrence of tremor\/convulsion and level of \u03b2-carbolines in the brain after administration of \u03b2-carbolines into mice. Pharmacol Biochem Behav 47(3):689\u2013699. https:\/\/doi.org\/10.1016\/0091-3057(94)90175-9","journal-title":"Pharmacol Biochem Behav"},{"key":"6517_CR112","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/340792","volume":"2013","author":"BF Kirmani","year":"2013","unstructured":"Kirmani BF, Mungall D (2013) Importance of video-EEG monitoring in the diagnosis of refractory panic attacks. Case Reports in Psychiatry 2013:340792. https:\/\/doi.org\/10.1155\/2013\/340792","journal-title":"Case Reports in Psychiatry"},{"issue":"2","key":"6517_CR113","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/15563657508988063","volume":"8","author":"JC Klock","year":"1975","unstructured":"Klock JC, Boerner U, Becker CE (1975) Coma, hyperthermia, and bleeding associated with massive LSD overdose a report of eight cases. Clin Toxicol 8(2):191\u2013203. https:\/\/doi.org\/10.3109\/15563657508988063","journal-title":"Clin Toxicol"},{"key":"6517_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.917199","volume":"13","author":"K Ko","year":"2022","unstructured":"Ko K, Knight G, Rucker JJ, Cleare AJ (2022) Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Front Psych 13:917199. https:\/\/doi.org\/10.3389\/fpsyt.2022.917199","journal-title":"Front Psych"},{"issue":"1","key":"6517_CR115","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/epi.12868","volume":"56","author":"S Kovac","year":"2015","unstructured":"Kovac S, Diehl B, Wehner T, Fois C, Toms N, Walker MC, Duncan JS (2015) Gelastic seizures: Incidence, clinical and EEG features in adult patients undergoing video-EEG telemetry. Epilepsia 56(1):e1-5. https:\/\/doi.org\/10.1111\/epi.12868","journal-title":"Epilepsia"},{"issue":"1","key":"6517_CR116","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1059-1311(97)80054-4","volume":"6","author":"U Kramer","year":"1997","unstructured":"Kramer U, Riviello JJ, Carmant L, Black PM, Madsen J, Holmes GL (1997) Clinical characteristics of complex partial seizures: A temporal versus a frontal lobe onset. Seizure 6(1):57\u201361. https:\/\/doi.org\/10.1016\/S1059-1311(97)80054-4","journal-title":"Seizure"},{"issue":"3","key":"6517_CR117","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","volume":"189","author":"K Krebs-Thomson","year":"2006","unstructured":"Krebs-Thomson K, Ruiz EM, Masten V, Buell M, Geyer MA (2006) The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology 189(3):319\u2013329. https:\/\/doi.org\/10.1007\/s00213-006-0566-1","journal-title":"Psychopharmacology"},{"key":"6517_CR118","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.wneu.2017.12.124","volume":"111","author":"KO Kulason","year":"2018","unstructured":"Kulason KO, Schneider JR, Rahme R, Pramanik B, Chong D, Boockvar JA (2018) Lesional temporal lobe epilepsy: Beware the deceitful \u201cPanic attack.\u201d World Neurosurgery 111:197\u2013200. https:\/\/doi.org\/10.1016\/j.wneu.2017.12.124","journal-title":"World Neurosurgery"},{"key":"6517_CR119","unstructured":"Kumar A, Sharma S (2022) Complex Partial Seizure. In: StatPearls. StatPearls Publishing, Treasure Island (FL). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519030\/. Accessed 10 Oct 2022"},{"key":"6517_CR120","first-page":"215","volume-title":"Handbook of medical hallucinogens","author":"R Lancelotta","year":"2021","unstructured":"Lancelotta R, Davis AK (2021) Therapeutic potential of fast-acting synthetic tryptamines. In: Grob CS, Grigsby J (eds) Handbook of medical hallucinogens, 1st edn. The Guilford Press, New York, pp 215\u2013232","edition":"1"},{"issue":"3","key":"6517_CR121","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/02791072.2020.1737763","volume":"52","author":"RL Lancelotta","year":"2020","unstructured":"Lancelotta RL, Davis AK (2020) Use of benefit enhancement strategies among 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) users: associations with mystical, challenging, and enduring effects. J Psychoactive Drugs 52(3):273\u2013281. https:\/\/doi.org\/10.1080\/02791072.2020.1737763","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"6517_CR122","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0969-8051(00)00107-4","volume":"27","author":"L Lanfumey","year":"2000","unstructured":"Lanfumey L, Hamon M (2000) Central 5-HT1A receptors: Regional distribution and functional characteristics. Nucl Med Biol 27(5):429\u2013435. https:\/\/doi.org\/10.1016\/S0969-8051(00)00107-4","journal-title":"Nucl Med Biol"},{"issue":"3","key":"6517_CR123","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.yebeh.2006.04.019","volume":"9","author":"EP Lansky","year":"2006","unstructured":"Lansky EP, Louis EKS (2006) Transcendental meditation: A double-edged sword in epilepsy? Epilepsy Behav 9(3):394\u2013400. https:\/\/doi.org\/10.1016\/j.yebeh.2006.04.019","journal-title":"Epilepsy Behav"},{"key":"6517_CR124","doi-asserted-by":"publisher","unstructured":"Lawrence, D. W., Carhart-Harris, R., Griffiths, R., & Timmermann, C. (2022). Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Scientific Reports, 12(1), Article 1. https:\/\/doi.org\/10.1038\/s41598-022-11999-8","DOI":"10.1038\/s41598-022-11999-8"},{"issue":"12","key":"6517_CR125","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1177\/0269881118793086","volume":"32","author":"JB Leonard","year":"2018","unstructured":"Leonard JB, Anderson B, Klein-Schwartz W (2018) Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. J Psychopharmacol 32(12):1286\u20131294. https:\/\/doi.org\/10.1177\/0269881118793086","journal-title":"J Psychopharmacol"},{"issue":"1","key":"6517_CR126","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/acs.chemrestox.5b00450","volume":"29","author":"S Leth-Petersen","year":"2016","unstructured":"Leth-Petersen S, Gabel-Jensen C, Gillings N, Lehel S, Hansen HD, Knudsen GM, Kristensen JL (2016) Metabolic fate of hallucinogenic NBOMes. Chem Res Toxicol 29(1):96\u2013100. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00450","journal-title":"Chem Res Toxicol"},{"key":"6517_CR127","unstructured":"Lettvin, J., & Leary, T. (Directors). (1967). MIT Debate on LSD: Dr. Jerry Lettvin + Dr. Timothy Leary - November 1967. https:\/\/www.youtube.com\/watch?v=Gq3Fp-xp0l0"},{"issue":"6","key":"6517_CR128","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1212\/wnl.52.6.1188","volume":"52","author":"F Leutmezer","year":"1999","unstructured":"Leutmezer F, Serles W, Bacher J, Gr\u00f6ppel G, Pataraia E, Aull S, Olbrich A, Czech T, Baumgartner C (1999) Genital automatisms in complex partial seizures. Neurology 52(6):1188\u20131191. https:\/\/doi.org\/10.1212\/wnl.52.6.1188","journal-title":"Neurology"},{"issue":"6","key":"6517_CR129","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0026-895X(25)12558-3","volume":"27","author":"JE Leysen","year":"1985","unstructured":"Leysen JE, Gommeren W, Gompel PV, Wynants J, Janssen PF, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27(6):600\u2013611","journal-title":"Mol Pharmacol"},{"issue":"9\u201310","key":"6517_CR130","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00213-016-4453-0","volume":"234","author":"ME Liechti","year":"2017","unstructured":"Liechti ME, Dolder PC, Schmid Y (2017) Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234(9\u201310):1499\u20131510. https:\/\/doi.org\/10.1007\/s00213-016-4453-0","journal-title":"Psychopharmacology"},{"key":"6517_CR131","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fnmol.2018.00312","volume":"11","author":"RV Lima da Cruz","year":"2018","unstructured":"Lima da Cruz RV, Moulin TC, Petiz LL, Le\u00e3o RN (2018) A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus. Front Mol Neurosci 11:312. https:\/\/doi.org\/10.3389\/fnmol.2018.00312","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"6517_CR132","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mehy.2014.07.015","volume":"83","author":"S Lindsay","year":"2014","unstructured":"Lindsay S (2014) Can hyper-synchrony in meditation lead to seizures? Similarities in meditative and epileptic brain states. Med Hypotheses 83(4):465\u2013472. https:\/\/doi.org\/10.1016\/j.mehy.2014.07.015","journal-title":"Med Hypotheses"},{"key":"6517_CR133","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","volume":"1461","author":"C Loane","year":"2012","unstructured":"Loane C, Politis M (2012) Buspirone: What is it all about? Brain Res 1461:111\u2013118. https:\/\/doi.org\/10.1016\/j.brainres.2012.04.032","journal-title":"Brain Res"},{"issue":"10","key":"6517_CR134","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/molecules26102948","volume":"26","author":"H Lowe","year":"2021","unstructured":"Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L (2021) The therapeutic potential of psilocybin. Molecules 26(10):2948. https:\/\/doi.org\/10.3390\/molecules26102948","journal-title":"Molecules"},{"issue":"10","key":"6517_CR135","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1212\/wnl.43.10.2113","volume":"43","author":"D Luciano","year":"1993","unstructured":"Luciano D, Devinsky O, Perrine K (1993) Crying seizures. Neurology 43(10):2113\u20132117. https:\/\/doi.org\/10.1212\/wnl.43.10.2113","journal-title":"Neurology"},{"issue":"1","key":"6517_CR136","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-3565(25)21483-5","volume":"228","author":"I Lucki","year":"1984","unstructured":"Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther 228(1):133\u2013139","journal-title":"J Pharmacol Exp Ther"},{"key":"6517_CR137","doi-asserted-by":"publisher","unstructured":"Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenb\u00e6k, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., Erritzoe, D., Ozenne, B., & Knudsen, G. M. (2019). Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology, 44(7), 1328\u20131334. https:\/\/doi.org\/10.1038\/s41386-019-0324-9","DOI":"10.1038\/s41386-019-0324-9"},{"issue":"9","key":"6517_CR138","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/bja\/47.9.1019","volume":"47","author":"J Malatinsky","year":"1975","unstructured":"Malatinsky J, Prochazka M, Samel M (1975) Respiratory failure as a seizure phenomenon. Br J Anaesth 47(9):1019\u20131022. https:\/\/doi.org\/10.1093\/bja\/47.9.1019","journal-title":"Br J Anaesth"},{"issue":"1","key":"6517_CR139","doi-asserted-by":"publisher","first-page":"39","DOI":"10.9740\/mhc.2017.01.039","volume":"7","author":"BJ Malcolm","year":"2018","unstructured":"Malcolm BJ, Lee KC (2018) Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Ment Health Clin 7(1):39\u201345. https:\/\/doi.org\/10.9740\/mhc.2017.01.039","journal-title":"Ment Health Clin"},{"key":"6517_CR140","doi-asserted-by":"publisher","first-page":"611278","DOI":"10.3389\/fnbeh.2020.611278","volume":"14","author":"C Mart\u00ednez-Aguirre","year":"2020","unstructured":"Mart\u00ednez-Aguirre C, Carmona-Cruz F, Velasco AL, Velasco F, Aguado-Carrillo G, Cu\u00e9llar-Herrera M, Rocha L (2020) Cannabidiol acts at 5-HT1A receptors in the human brain: Relevance for treating temporal lobe epilepsy. Front Behav Neurosci 14:611278. https:\/\/doi.org\/10.3389\/fnbeh.2020.611278","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"6517_CR141","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","volume":"29","author":"DJ Mckenna","year":"1990","unstructured":"Mckenna DJ, Repke DB, Lo L, Peroutka SJ (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29(3):193\u2013198. https:\/\/doi.org\/10.1016\/0028-3908(90)90001-8","journal-title":"Neuropharmacology"},{"issue":"12","key":"6517_CR142","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/jnnp.2006.088492","volume":"78","author":"BN McLean","year":"2007","unstructured":"McLean BN, Wimalaratna S (2007) Sudden death in epilepsy recorded in ambulatory EEG. J Neurol Neurosurg Psychiatry 78(12):1395\u20131397. https:\/\/doi.org\/10.1136\/jnnp.2006.088492","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6517_CR143","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.0099","author":"S McNamee","year":"2023","unstructured":"McNamee S, Devenot N, Buisson M (2023) Studying harms is key to improving psychedelic-assisted therapy\u2014Participants call for changes to research landscape. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.0099","journal-title":"JAMA Psychiatry"},{"key":"6517_CR144","unstructured":"Meldrum, B. S., & Naquet, R. (1970). Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio). Br J Pharmacol, 40(1), 144P+."},{"key":"6517_CR145","unstructured":"Metzner, R. (2013). The toad and the jaguar: A field report of underground research on a visionary medicine: Bufo alvarius and 5-methoxy-dimethyltryptamine (1st edition). Regent Press."},{"key":"6517_CR146","doi-asserted-by":"publisher","unstructured":"Michael P, Luke D, Robinson O (2023) This is your brain on death: A comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience.\u00a0Front Psychol\u00a014:1083361. https:\/\/doi.org\/10.3389\/fpsyg.2023.1083361","DOI":"10.3389\/fpsyg.2023.1083361"},{"key":"6517_CR147","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fpsyg.2018.01475","volume":"9","author":"R Milli\u00e8re","year":"2018","unstructured":"Milli\u00e8re R, Carhart-Harris RL, Roseman L, Trautwein F-M, Berkovich-Ohana A (2018) Psychedelics, meditation, and self-consciousness. Front Psychol 9:1475. https:\/\/doi.org\/10.3389\/fpsyg.2018.01475","journal-title":"Front Psychol"},{"key":"6517_CR148","doi-asserted-by":"publisher","unstructured":"Mirsattari, S. M., Gofton, T. E., & Chong, D. J. (2011). Misdiagnosis of epileptic seizures as manifestations of psychiatric illnesses. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 38(3), 487\u2013493. https:\/\/doi.org\/10.1017\/s0317167100011914","DOI":"10.1017\/s0317167100011914"},{"issue":"6","key":"6517_CR149","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0090-3019(90)90155-I","volume":"33","author":"H Morgan","year":"1990","unstructured":"Morgan H (1990) Dostoevsky\u2019s epilepsy: A case report and comparison. Surg Neurol 33(6):413\u2013416. https:\/\/doi.org\/10.1016\/0090-3019(90)90155-I","journal-title":"Surg Neurol"},{"issue":"6","key":"6517_CR150","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00213-022-06066-z","volume":"239","author":"F M\u00fcller","year":"2022","unstructured":"M\u00fcller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (2022) Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology 239(6):1933\u20131943. https:\/\/doi.org\/10.1007\/s00213-022-06066-z","journal-title":"Psychopharmacology"},{"issue":"2","key":"6517_CR151","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005053-198802000-00010","volume":"176","author":"H Naito","year":"1988","unstructured":"Naito H, Matsui N (1988) Temporal lobe epilepsy with ictal ecstatic state and interictal behavior of hypergraphia. J Nerv Ment Dis 176(2):123\u2013124. https:\/\/doi.org\/10.1097\/00005053-198802000-00010","journal-title":"J Nerv Ment Dis"},{"issue":"05","key":"6517_CR152","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/a-1524-2794","volume":"54","author":"SM Nayak","year":"2021","unstructured":"Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (2021) Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: An analysis of online psychedelic experience reports. Pharmacopsychiatry 54(05):240\u2013245. https:\/\/doi.org\/10.1055\/a-1524-2794","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"6517_CR153","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archneur.1968.00480020085008","volume":"19","author":"DA Nelson","year":"1968","unstructured":"Nelson DA (1968) Respiratory arrest from seizure discharges in limbic system: report of cases. Arch Neurol 19(2):199. https:\/\/doi.org\/10.1001\/archneur.1968.00480020085008","journal-title":"Arch Neurol"},{"key":"6517_CR154","doi-asserted-by":"publisher","unstructured":"Netto, I., & Phutane, V. H. (2012). Reversible lithium neurotoxicity: Review of the literature. The Primary Care Companion for CNS Disorders, 14(1), PCC.11r01197. https:\/\/doi.org\/10.4088\/PCC.11r01197","DOI":"10.4088\/PCC.11r01197"},{"issue":"3","key":"6517_CR155","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1528-1157.1989.tb05302.x","volume":"30","author":"RS Neuman","year":"1989","unstructured":"Neuman RS, Thompson PM (1989) Serotonin mediates suppression of focal epileptiform activity induced by noxious stimulation. Epilepsia 30(3):307\u2013313. https:\/\/doi.org\/10.1111\/j.1528-1157.1989.tb05302.x","journal-title":"Epilepsia"},{"key":"6517_CR156","doi-asserted-by":"publisher","first-page":"107937","DOI":"10.1016\/j.pharmthera.2021.107937","volume":"229","author":"A Newman-Tancredi","year":"2022","unstructured":"Newman-Tancredi A, Depoort\u00e8re RY, Kleven MS, Ko\u0142aczkowski M, Zimmer L (2022) Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders. Pharmacol Ther 229:107937. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107937","journal-title":"Pharmacol Ther"},{"issue":"2","key":"6517_CR157","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68(2):264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"issue":"5","key":"6517_CR158","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1021\/cr078224o","volume":"108","author":"DE Nichols","year":"2008","unstructured":"Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108(5):1614\u20131641. https:\/\/doi.org\/10.1021\/cr078224o","journal-title":"Chem Rev"},{"key":"6517_CR159","doi-asserted-by":"publisher","unstructured":"Nichols, D. E., Nichols, C. D., & Hendricks, P. S. (2022). Proposed consensus statement on defining psychedelic drugs. Psychedelic Medicine, psymed.2022.0008. https:\/\/doi.org\/10.1089\/psymed.2022.0008","DOI":"10.1089\/psymed.2022.0008"},{"issue":"2\u20133","key":"6517_CR160","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0014-2999(98)00746-8","volume":"361","author":"CK Nielsen","year":"1998","unstructured":"Nielsen CK (1998) Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B\/1D and 5-HT2A receptor antagonists. Eur J Pharmacol 361(2\u20133):185\u2013190. https:\/\/doi.org\/10.1016\/s0014-2999(98)00746-8","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"6517_CR161","doi-asserted-by":"publisher","first-page":"127","DOI":"10.9740\/mhc.n127568","volume":"2","author":"CY Oh","year":"2012","unstructured":"Oh CY, Bainbridge J (2012) Lowering the seizure threshold associated with antidepressants, stimulants, antipsychotics, and others. Ment Health Clin 2(5):127\u2013128. https:\/\/doi.org\/10.9740\/mhc.n127568","journal-title":"Ment Health Clin"},{"issue":"5","key":"6517_CR162","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","volume":"237","author":"JA Olson","year":"2020","unstructured":"Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissi\u00e8re SPL (2020) Tripping on nothing: Placebo psychedelics and contextual factors. Psychopharmacology 237(5):1371\u20131382. https:\/\/doi.org\/10.1007\/s00213-020-05464-5","journal-title":"Psychopharmacology"},{"issue":"6","key":"6517_CR163","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00213-021-05964-y","volume":"239","author":"G Ona","year":"2022","unstructured":"Ona G, Rocha JM, Bouso JC, Hallak JEC, Borr\u00e0s T, Colomina MT, Dos Santos RG (2022) The adverse events of ibogaine in humans: An updated systematic review of the literature (2015\u20132020). Psychopharmacology 239(6):1977\u20131987. https:\/\/doi.org\/10.1007\/s00213-021-05964-y","journal-title":"Psychopharmacology"},{"key":"6517_CR164","unstructured":"Oroc, J. (2009). Tryptamine palace: 5-MeO-DMT and the sonoran desert toad. Park Street Press."},{"key":"6517_CR165","unstructured":"Ortiz, A. (2022, October 18). The toad boom: The false narrative of ancestral 5-MeO-DMT use. Points: Short & insightful writing about the long & complex history of drugs & alcohol. https:\/\/pointshistory.com\/2022\/10\/18\/the-toad-boom\/"},{"key":"6517_CR166","doi-asserted-by":"publisher","first-page":"1049643","DOI":"10.3389\/fpsyt.2022.1049643","volume":"13","author":"AM Ortiz Bernal","year":"2022","unstructured":"Ortiz Bernal AM, Raison CL, Lancelotta RL, Davis AK (2022) Reactivations after 5-methoxy-N, N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon\u2019s predictors and its emotional valence. Front Psych 13:1049643. https:\/\/doi.org\/10.3389\/fpsyt.2022.1049643","journal-title":"Front Psych"},{"key":"6517_CR167","unstructured":"Ott, J. (1993). Entheogenic drugs, their plant sources and history (2nd ed.). Natural Products Co."},{"issue":"3","key":"6517_CR168","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/02791072.2001.10400574","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001) Pharma\u00f1opo\u2014Psychonautics: human intranasal, sublingual, intrarectal, pulmonary and Oral pharmacology of bufotenine. J Psychoactive Drugs 33(3):273\u2013281. https:\/\/doi.org\/10.1080\/02791072.2001.10400574","journal-title":"J Psychoactive Drugs"},{"key":"6517_CR169","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.yebeh.2018.03.016","volume":"84","author":"T Page","year":"2018","unstructured":"Page T, Rugg-Gunn FJ (2018) Bitemporal seizure spread and its effect on autonomic dysfunction. Epilepsy Behav 84:166\u2013172. https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.016","journal-title":"Epilepsy Behav"},{"issue":"1","key":"6517_CR170","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00124509-200403000-00004","volume":"20","author":"D Pagnin","year":"2004","unstructured":"Pagnin D, de Queiroz V, Pini S, Cassano GB (2004) Efficacy of ECT in depression: A meta-analytic review. J ECT 20(1):13\u201320","journal-title":"J ECT"},{"issue":"1","key":"6517_CR171","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/02698811211066709","volume":"36","author":"JM Peill","year":"2022","unstructured":"Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL (2022) Validation of the psychological insight scale: A new scale to assess psychological insight following a psychedelic experience. J Psychopharmacol (Oxford, England) 36(1):31\u201345. https:\/\/doi.org\/10.1177\/02698811211066709","journal-title":"J Psychopharmacol (Oxford, England)"},{"issue":"11","key":"6517_CR172","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0166-2236(88)90011-2","volume":"11","author":"SJ Peroutka","year":"1988","unstructured":"Peroutka SJ (1988) 5-hydroxytryptamine receptor subtypes: Molecular, biochemical and physiological characterization. Trends Neurosci 11(11):496\u2013500. https:\/\/doi.org\/10.1016\/0166-2236(88)90011-2","journal-title":"Trends Neurosci"},{"key":"6517_CR173","doi-asserted-by":"publisher","unstructured":"Persinger, M. A. (1983). Religious and mystical experiences as artifacts of temporal lobe function: A general hypothesis. Perceptual and Motor Skills, 57(3_suppl), 1255\u20131262. https:\/\/doi.org\/10.2466\/pms.1983.57.3f.1255","DOI":"10.2466\/pms.1983.57.3f.1255"},{"issue":"11","key":"6517_CR174","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/brainsci11111384","volume":"11","author":"F Picard","year":"2021","unstructured":"Picard F, Bossaerts P, Bartolomei F (2021) Epilepsy and ecstatic experiences: The role of the insula. Brain Sci 11(11):1384. https:\/\/doi.org\/10.3390\/brainsci11111384","journal-title":"Brain Sci"},{"issue":"3","key":"6517_CR175","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.yebeh.2009.09.013","volume":"16","author":"F Picard","year":"2009","unstructured":"Picard F, Craig AD (2009) Ecstatic epileptic seizures: A potential window on the neural basis for human self-awareness. Epilepsy Behav 16(3):539\u2013546. https:\/\/doi.org\/10.1016\/j.yebeh.2009.09.013","journal-title":"Epilepsy Behav"},{"key":"6517_CR176","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yebeh.2013.09.036","volume":"30","author":"F Picard","year":"2014","unstructured":"Picard F, Kurth F (2014) Ictal alterations of consciousness during ecstatic seizures. Epilepsy Behav 30:58\u201361. https:\/\/doi.org\/10.1016\/j.yebeh.2013.09.036","journal-title":"Epilepsy Behav"},{"issue":"6","key":"6517_CR177","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1176\/ajp.149.6.843b","volume":"149","author":"W Picker","year":"1992","unstructured":"Picker W, Lerman A, Hajal F (1992) Potential interaction of LSD and fluoxetine. Am J Psychiatry 149(6):843\u2013844. https:\/\/doi.org\/10.1176\/ajp.149.6.843b","journal-title":"Am J Psychiatry"},{"key":"6517_CR178","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yebeh.2015.10.009","volume":"53","author":"N Pietrafusa","year":"2015","unstructured":"Pietrafusa N, de Palma L, De Benedictis A, Trivisano M, Marras CE, Vigevano F, Specchio N (2015) Ictal vomiting as a sign of temporal lobe epilepsy confirmed by stereo-EEG and surgical outcome. Epilepsy Behav 53:112\u2013116. https:\/\/doi.org\/10.1016\/j.yebeh.2015.10.009","journal-title":"Epilepsy Behav"},{"issue":"4","key":"6517_CR179","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.yebeh.2009.06.004","volume":"15","author":"J Pinikahana","year":"2009","unstructured":"Pinikahana J, Dono J (2009) The lived experience of initial symptoms of and factors triggering epileptic seizures. Epilepsy Behav 15(4):513\u2013520. https:\/\/doi.org\/10.1016\/j.yebeh.2009.06.004","journal-title":"Epilepsy Behav"},{"issue":"4","key":"6517_CR180","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","volume":"26","author":"T Pokorny","year":"2016","unstructured":"Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX (2016) Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience. Eur Neuropsychopharmacol 26(4):756\u2013766. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.01.005","journal-title":"Eur Neuropsychopharmacol"},{"key":"6517_CR181","doi-asserted-by":"publisher","unstructured":"Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., St\u00e4mpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., Vollenweider, F. X., & Anticevic, A. (2018). Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife, 7, e35082. https:\/\/doi.org\/10.7554\/eLife.35082","DOI":"10.7554\/eLife.35082"},{"issue":"2","key":"6517_CR182","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.brs.2022.02.003","volume":"15","author":"AD Ramnauth","year":"2022","unstructured":"Ramnauth AD, Maynard KR, Kardian AS, Phan BN, Tippani M, Rajpurohit S, Hobbs JW, Page SC, Jaffe AE, Martinowich K (2022) Induction of Bdnf from promoter I following electroconvulsive seizures contributes to structural plasticity in neurons of the piriform cortex. Brain Stimul 15(2):427\u2013433. https:\/\/doi.org\/10.1016\/j.brs.2022.02.003","journal-title":"Brain Stimul"},{"issue":"2","key":"6517_CR183","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/ipj.ipj_94_19","volume":"29","author":"N Rathi","year":"2020","unstructured":"Rathi N, Saldanha D, Chaudhury S, Mujawar S (2020) Self-injurious behavior in epilepsy. Ind Psychiatry J 29(2):352\u2013354. https:\/\/doi.org\/10.4103\/ipj.ipj_94_19","journal-title":"Ind Psychiatry J"},{"key":"6517_CR184","doi-asserted-by":"publisher","first-page":"760671","DOI":"10.3389\/fphar.2021.760671","volume":"12","author":"J Reckweg","year":"2021","unstructured":"Reckweg J, Mason NL, van Leeuwen C, Toennes SW, Terwey TH, Ramaekers JG (2021) A phase 1, dose-ranging study to assess safety and psychoactive effects of a vaporized 5-methoxy-N, N-dimethyltryptamine formulation (GH001) in healthy volunteers. Front Pharmacol 12:760671. https:\/\/doi.org\/10.3389\/fphar.2021.760671","journal-title":"Front Pharmacol"},{"issue":"1","key":"6517_CR185","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jnc.15587","volume":"162","author":"JT Reckweg","year":"2022","unstructured":"Reckweg JT, Uthaug MV, Szabo A, Davis AK, Lancelotta R, Mason NL, Ramaekers JG (2022) The clinical pharmacology and potential therapeutic applications of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT). J Neurochem 162(1):128\u2013146. https:\/\/doi.org\/10.1111\/jnc.15587","journal-title":"J Neurochem"},{"key":"6517_CR186","doi-asserted-by":"publisher","first-page":"1133414","DOI":"10.3389\/fpsyt.2023.1133414","volume":"14","author":"JT Reckweg","year":"2023","unstructured":"Reckweg JT, van Leeuwen CJ, Henquet C, van Amelsvoort T, Theunissen EL, Mason NL, Paci R, Terwey TH, Ramaekers JG (2023) A phase 1\/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N, N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression. Front Psych 14:1133414. https:\/\/doi.org\/10.3389\/fpsyt.2023.1133414","journal-title":"Front Psych"},{"issue":"3","key":"6517_CR187","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1212\/WNL.33.3.323","volume":"33","author":"GM Remillard","year":"1983","unstructured":"Remillard GM, Andermann F, Testa GF, Gloor P, Aube M, Martin JB, Feindel W, Guberman A, Simpson C (1983) Sexual ictal manifestations predominate in women with temporal lobe epilepsy: A finding suggesting sexual dimorphism in the human brain. Neurology 33(3):323\u2013323. https:\/\/doi.org\/10.1212\/WNL.33.3.323","journal-title":"Neurology"},{"key":"6517_CR188","unstructured":"Reverend K (2002)\u00a05-MeO-DMT (smoked)\u2014Erowid Exp\u2014\u2019Convulsions, Vomiting Blood.\u2019. https:\/\/erowid.org\/experiences\/exp.php?ID=15342. Accessed 14 June 2023"},{"issue":"8","key":"6517_CR189","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","volume":"26","author":"A Rickli","year":"2016","unstructured":"Rickli A, Moning OD, Hoener MC, Liechti ME (2016) Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol 26(8):1327\u20131337. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.05.001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"6517_CR190","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00406-023-01590-1","volume":"273","author":"JM Rocha","year":"2023","unstructured":"Rocha JM, Reis JAS, Bouso JC, Hallak JEC, Dos Santos RG (2023) Identifying setting factors associated with improved ibogaine safety: A systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 273(7):1527\u20131542. https:\/\/doi.org\/10.1007\/s00406-023-01590-1","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"6517_CR191","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0269881120970879","volume":"35","author":"RL Rothberg","year":"2021","unstructured":"Rothberg RL, Azhari N, Haug NA, Dakwar E (2021) Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial. J Psychopharmacol 35(2):150\u2013158. https:\/\/doi.org\/10.1177\/0269881120970879","journal-title":"J Psychopharmacol"},{"issue":"9","key":"6517_CR192","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.biopsych.2020.03.021","volume":"88","author":"B Roy","year":"2020","unstructured":"Roy B, Han J, Hope KA, Peters TL, Palmer G, Reiter LT (2020) An unbiased drug screen for seizure suppressors in duplication 15q syndrome reveals 5-HT1A and dopamine pathway activation as potential therapies. Biol Psychiat 88(9):698\u2013709. https:\/\/doi.org\/10.1016\/j.biopsych.2020.03.021","journal-title":"Biol Psychiat"},{"key":"6517_CR193","doi-asserted-by":"publisher","first-page":"113778","DOI":"10.1016\/j.expneurol.2021.113778","volume":"343","author":"D Rudin","year":"2021","unstructured":"Rudin D, Liechti ME, Luethi D (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Exp Neurol 343:113778. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113778","journal-title":"Exp Neurol"},{"issue":"2","key":"6517_CR194","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/WCO.0000000000000907","volume":"34","author":"P Ryvlin","year":"2021","unstructured":"Ryvlin P, Nguyen DK (2021) Insular seizures and epilepsies: Ictal semiology and minimal invasive surgery. Curr Opin Neurol 34(2):153\u2013165. https:\/\/doi.org\/10.1097\/WCO.0000000000000907","journal-title":"Curr Opin Neurol"},{"key":"6517_CR195","doi-asserted-by":"publisher","first-page":"107872","DOI":"10.1016\/j.pharmthera.2021.107872","volume":"227","author":"K Sa\u0142aciak","year":"2021","unstructured":"Sa\u0142aciak K, Pytka K (2021) Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases? Pharmacol Ther 227:107872. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107872","journal-title":"Pharmacol Ther"},{"issue":"3","key":"6517_CR196","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/schbul\/sby095","volume":"45","author":"MT Samara","year":"2019","unstructured":"Samara MT, Nikolakopoulou A, Salanti G, Leucht S (2019) How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? an analysis based on individual patient data from randomized controlled trials. Schizophr Bull 45(3):639\u2013646. https:\/\/doi.org\/10.1093\/schbul\/sby095","journal-title":"Schizophr Bull"},{"issue":"26","key":"6517_CR197","doi-asserted-by":"publisher","first-page":"14731","DOI":"10.1073\/pnas.97.26.14731","volume":"97","author":"Z Sarnyai","year":"2000","unstructured":"Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, T\u00f3th M (2000) Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin 1A receptors. Proc Natl Acad Sci 97(26):14731\u201314736. https:\/\/doi.org\/10.1073\/pnas.97.26.14731","journal-title":"Proc Natl Acad Sci"},{"issue":"22","key":"6517_CR198","doi-asserted-by":"publisher","first-page":"00129","DOI":"10.1016\/j.encep.2022.05.002","volume":"S0013\u20137006","author":"A Sauvaget","year":"2022","unstructured":"Sauvaget A, Bulteau S, Galvao F, Szekely D, Fossati P, Poulet E (2022) ECT: An essential therapy in psychiatry. L\u2019encephale S0013\u20137006(22):00129\u201300134. https:\/\/doi.org\/10.1016\/j.encep.2022.05.002","journal-title":"L\u2019encephale"},{"key":"6517_CR199","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yebeh.2016.09.043","volume":"66","author":"SA Savage","year":"2017","unstructured":"Savage SA, Butler CR, Milton F, Han Y, Zeman AZ (2017) On the nose: Olfactory disturbances in transient epileptic amnesia. Epilepsy & Behavior\u202f: e&b 66:113\u2013119. https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.043","journal-title":"Epilepsy & Behavior : e&b"},{"issue":"8","key":"6517_CR200","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1212\/01.wnl.0000123696.98166.af","volume":"62","author":"I Savic","year":"2004","unstructured":"Savic I, Lindstr\u00f6m P, Guly\u00e1s B, Halldin C, Andr\u00e9e B, Farde L (2004) Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62(8):1343\u20131351. https:\/\/doi.org\/10.1212\/01.wnl.0000123696.98166.af","journal-title":"Neurology"},{"issue":"2","key":"6517_CR201","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1684\/j.1950-6945.2003.tb00569.x","volume":"5","author":"M Sazgar","year":"2003","unstructured":"Sazgar M, Carlen PL, Wennberg R (2003) Panic attack semiology in right temporal lobe epilepsy. Epileptic Disord 5(2):93\u2013100","journal-title":"Epileptic Disord"},{"issue":"1\u20132","key":"6517_CR202","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jns.2006.02.017","volume":"246","author":"A Scalise","year":"2006","unstructured":"Scalise A, Placidi F, Diomedi M, De Simone R, Gigli GL (2006) Panic disorder or epilepsy? A case report. J Neurol Sci 246(1\u20132):173\u2013175. https:\/\/doi.org\/10.1016\/j.jns.2006.02.017","journal-title":"J Neurol Sci"},{"key":"6517_CR203","doi-asserted-by":"publisher","unstructured":"Schep, L. J., Slaughter, R. J., Watts, M., Mackenzie, E., & Gee, P. (2023). The clinical toxicology of ketamine. Clinical Toxicology (Philadelphia, Pa.), 61(6), 415\u2013428. https:\/\/doi.org\/10.1080\/15563650.2023.2212125","DOI":"10.1080\/15563650.2023.2212125"},{"issue":"2","key":"6517_CR204","first-page":"105","volume":"1","author":"RF Schlemmer","year":"1977","unstructured":"Schlemmer RF, Narasimhachari N, Thompson VD, Davis JM (1977) The effect of a hallucinogen, 5-methoxy N, N-dimethyltryptamine, on primate social behavior. Commun Psychopharmacol 1(2):105\u2013118","journal-title":"Commun Psychopharmacol"},{"key":"6517_CR205","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.euroneuro.2022.07.183","volume":"63","author":"G Schurgers","year":"2022","unstructured":"Schurgers G, Walter S, Pishva E, Guloksuz S, Peerbooms O, Incio LR, Arts BMG, Kenis G, Rutten BPF (2022) Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy. Eur Neuropsychopharmacol 63:60\u201370. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.07.183","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"6517_CR206","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/WNL.6.4.275","volume":"6","author":"BE Schwarz","year":"1956","unstructured":"Schwarz BE, Bickford RG, Mulder DW, Rome HP (1956) Mescaline and LSD-25 in activation of temporal lobe epilepsy. Neurology 6(4):275\u2013275. https:\/\/doi.org\/10.1212\/WNL.6.4.275","journal-title":"Neurology"},{"key":"6517_CR207","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fpsyt.2019.00896","volume":"10","author":"JD Sexton","year":"2020","unstructured":"Sexton JD, Nichols CD, Hendricks PS (2020) Population survey data informing the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics. Front Psych 10:896. https:\/\/doi.org\/10.3389\/fpsyt.2019.00896","journal-title":"Front Psych"},{"issue":"179","key":"6517_CR208","first-page":"239","volume":"49","author":"DR Shakya","year":"2010","unstructured":"Shakya DR, Shyangwa PM, Pandey AK, Subedi S, Yadav S (2010) Self injurious behavior in temporal lobe epilepsy. JNMA J Nepal Med Assoc 49(179):239\u2013242","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"8","key":"6517_CR209","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/138920010794233495","volume":"11","author":"H-W Shen","year":"2010","unstructured":"Shen H-W, Jiang X-L, Winter JC, Yu A-M (2010) Psychedelic 5-methoxy-N, N-dimethyltryptamine: Metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab 11(8):659\u2013666","journal-title":"Curr Drug Metab"},{"issue":"49","key":"6517_CR210","doi-asserted-by":"publisher","first-page":"32067","DOI":"10.1021\/acsomega.0c05099","volume":"5","author":"AM Sherwood","year":"2020","unstructured":"Sherwood AM, Claveau R, Lancelotta R, Kaylo KW, Lenoch K (2020) Synthesis and characterization of 5-MeO-DMT succinate for clinical use. ACS Omega 5(49):32067\u201332075. https:\/\/doi.org\/10.1021\/acsomega.0c05099","journal-title":"ACS Omega"},{"key":"6517_CR211","unstructured":"Shulgin, A. T., & Shulgin, A. (1997). Tihkal: The continuation. Transform."},{"key":"6517_CR212","unstructured":"Siebert, A. (2022, February 28). Could 5-MeO-DMT allow for more affordable psychedelic-assisted therapy? Beckley psytech thinks so. Forbes. https:\/\/www.forbes.com\/sites\/amandasiebert\/2022\/02\/28\/could-5-meo-dmt-allow-for-more-affordable-psychedelic-assisted-therapy--beckley-psytech-thinks-so\/"},{"key":"6517_CR213","doi-asserted-by":"publisher","first-page":"109586","DOI":"10.1016\/j.drugalcdep.2022.109586","volume":"239","author":"O Simonsson","year":"2022","unstructured":"Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS (2022) Prevalence and associations of classic psychedelic-related seizures in a population-based sample. Drug Alcohol Depend 239:109586. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109586","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"6517_CR214","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/epi.16819","volume":"62","author":"N Sinha","year":"2021","unstructured":"Sinha N, Peternell N, Schroeder GM, de Tisi J, Vos SB, Winston GP, Duncan JS, Wang Y, Taylor PN (2021) Focal to bilateral tonic\u2013clonic seizures are associated with widespread network abnormality in temporal lobe epilepsy. Epilepsia 62(3):729\u2013741. https:\/\/doi.org\/10.1111\/epi.16819","journal-title":"Epilepsia"},{"key":"6517_CR215","doi-asserted-by":"publisher","unstructured":"Skidmore, C. T. (2016). Adult focal epilepsies. CONTINUUM: Lifelong Learning in Neurology, 22(1), 94. https:\/\/doi.org\/10.1212\/CON.0000000000000290","DOI":"10.1212\/CON.0000000000000290"},{"key":"6517_CR216","unstructured":"Skully. (2001, February 26). 5-MeO-DMT - Erowid Exp\u2014\u2019My observations of 5-Meo\u2019. Erowid. https:\/\/erowid.org\/experiences\/exp.php?ID=5302"},{"issue":"3","key":"6517_CR217","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1528-1157.1989.tb05305.x","volume":"30","author":"MR Sperling","year":"1989","unstructured":"Sperling MR, Lieb JP, Engel J, Crandall PH (1989) Prognostic significance of independent auras in temporal lobe seizures. Epilepsia 30(3):322\u2013331. https:\/\/doi.org\/10.1111\/j.1528-1157.1989.tb05305.x","journal-title":"Epilepsia"},{"issue":"3","key":"6517_CR218","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.410280304","volume":"28","author":"MR Sperling","year":"1990","unstructured":"Sperling MR, O\u2019Connor MJ (1990) Auras and subclinical seizures: Characteristics and prognostic significance. Ann Neurol 28(3):320\u2013328. https:\/\/doi.org\/10.1002\/ana.410280304","journal-title":"Ann Neurol"},{"issue":"1","key":"6517_CR219","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1525\/dcqr.2021.10.1.50","volume":"10","author":"L Spiers","year":"2021","unstructured":"Spiers L (2021) Dreamy states and cosmic wanderings. Departures in Critical Qualitative Research 10(1):50\u201377. https:\/\/doi.org\/10.1525\/dcqr.2021.10.1.50","journal-title":"Departures in Critical Qualitative Research"},{"issue":"1","key":"6517_CR220","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","volume":"73","author":"RJ Strassman","year":"1995","unstructured":"Strassman RJ (1995) Human psychopharmacology of N, N-dimethyltryptamine. Behav Brain Res 73(1):121\u2013124. https:\/\/doi.org\/10.1016\/0166-4328(96)00081-2","journal-title":"Behav Brain Res"},{"issue":"8","key":"6517_CR221","doi-asserted-by":"publisher","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5(8):e12412. https:\/\/doi.org\/10.1371\/journal.pone.0012412","journal-title":"PLoS One"},{"issue":"2","key":"6517_CR222","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","volume":"56","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion, a novel class of potent hallucinogens: A review of the literature. Psychosomatics 56(2):129\u2013139. https:\/\/doi.org\/10.1016\/j.psym.2014.11.002","journal-title":"Psychosomatics"},{"issue":"11","key":"6517_CR223","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF02157378","volume":"12","author":"St Sz\u00e1ra","year":"1956","unstructured":"Sz\u00e1ra St (1956) Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia 12(11):441\u2013442. https:\/\/doi.org\/10.1007\/BF02157378","journal-title":"Experientia"},{"issue":"6","key":"6517_CR224","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.50.6.673","volume":"50","author":"DC Taylor","year":"1987","unstructured":"Taylor DC, Lochery M (1987) Temporal lobe epilepsy: Origin and significance of simple and complex auras. J Neurol Neurosurg Psychiatry 50(6):673\u2013681. https:\/\/doi.org\/10.1136\/jnnp.50.6.673","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6517_CR225","unstructured":"The Conclave. (n.d.). Intergration guidlines. The Conclave. Retrieved October 11, 2022, from https:\/\/theconclave.info\/"},{"issue":"5","key":"6517_CR226","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1535-7597.2003.03508.x","volume":"3","author":"WH Theodore","year":"2003","unstructured":"Theodore WH (2003) Does serotonin play a role in epilepsy? Epilepsy Currents 3(5):173\u2013177. https:\/\/doi.org\/10.1046\/j.1535-7597.2003.03508.x","journal-title":"Epilepsy Currents"},{"issue":"12","key":"6517_CR227","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41582-021-00574-w","volume":"17","author":"RD Thijs","year":"2021","unstructured":"Thijs RD, Ryvlin P, Surges R (2021) Autonomic manifestations of epilepsy: Emerging pathways to sudden death? Nat Rev Neurol 17(12):774\u2013788. https:\/\/doi.org\/10.1038\/s41582-021-00574-w","journal-title":"Nat Rev Neurol"},{"issue":"7267","key":"6517_CR228","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/bmj.321.7267.1002","volume":"321","author":"SA Thompson","year":"2000","unstructured":"Thompson SA (2000) Partial seizures presenting as panic attacks. BMJ 321(7267):1002\u20131003. https:\/\/doi.org\/10.1136\/bmj.321.7267.1002","journal-title":"BMJ"},{"issue":"9","key":"6517_CR229","first-page":"947","volume":"105","author":"HJ Thurlow","year":"1971","unstructured":"Thurlow HJ, Girvin JP (1971) Use of anti-epileptic medication in treating \u201cflashbacks\u201d from hallucinogenic drugs. Can Med Assoc J 105(9):947\u2013948","journal-title":"Can Med Assoc J"},{"issue":"5","key":"6517_CR230","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1212\/01.WNL.0000049930.93113.20","volume":"60","author":"MT Toczek","year":"2003","unstructured":"Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Eckelman WC, Theodore WH (2003) PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60(5):749\u2013756. https:\/\/doi.org\/10.1212\/01.WNL.0000049930.93113.20","journal-title":"Neurology"},{"issue":"1","key":"6517_CR231","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.neuropsych.11020039","volume":"24","author":"G Tremont","year":"2012","unstructured":"Tremont G, Smith MM, Bauer L, Alosco ML, Davis JD, Blum AS, LaFrance WC (2012) Comparison of personality characteristics on the bear-fedio inventory between patients with epilepsy and those with non-epileptic seizures. J Neuropsychiatry Clin Neurosci 24(1):47\u201352. https:\/\/doi.org\/10.1176\/appi.neuropsych.11020039","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6517_CR232","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3389\/fpsyg.2018.01424","volume":"9","author":"C Timmermann","year":"2018","unstructured":"Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R (2018) DMT Models the Near-Death Experience. Front Psychol 9:1424. https:\/\/doi.org\/10.3389\/fpsyg.2018.01424","journal-title":"Front Psychol"},{"issue":"5","key":"6517_CR233","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3892\/etm.2021.10716","volume":"22","author":"S Trifu","year":"2021","unstructured":"Trifu S, Sevcenco A, St\u0103nescu M, Dr\u0103goi AM, Cristea MB (2021) Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (review). Exp Ther Med 22(5):1281. https:\/\/doi.org\/10.3892\/etm.2021.10716","journal-title":"Exp Ther Med"},{"issue":"3","key":"6517_CR234","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.yebeh.2006.05.006","volume":"9","author":"M Trimble","year":"2006","unstructured":"Trimble M, Freeman A (2006) An investigation of religiosity and the gastaut-geschwind syndrome in patients with temporal lobe epilepsy. Epilepsy Behav 9(3):407\u2013414. https:\/\/doi.org\/10.1016\/j.yebeh.2006.05.006","journal-title":"Epilepsy Behav"},{"key":"6517_CR235","doi-asserted-by":"publisher","unstructured":"Tyagi, R., Saraf, T. S., & Canal, C. E. (2023). The serotonergic psychedelic N,N-Dipropyltryptamine prevents seizures in a mouse model of fragile X syndrome via an apparent non-serotonergic mechanism. Journal of Pharmacology and Experimental Therapeutics, 385(S3). https:\/\/doi.org\/10.1124\/jpet.122.145310","DOI":"10.1124\/jpet.122.145310"},{"issue":"2","key":"6517_CR236","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1556\/2054.2020.00123","volume":"4","author":"MV Uthaug","year":"2020","unstructured":"Uthaug MV, Lancelotta R, Ortiz Bernal AM, Davis AK, Ramaekers JG (2020a) A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting. J Psychedelic Stud 4(2):104\u2013113. https:\/\/doi.org\/10.1556\/2054.2020.00123","journal-title":"J Psychedelic Stud"},{"issue":"3","key":"6517_CR237","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00213-019-05414-w","volume":"237","author":"MV Uthaug","year":"2020","unstructured":"Uthaug MV, Lancelotta R, Szabo A, Davis AK, Riba J, Ramaekers JG (2020b) Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: Effects on salivary IL-6, cortisol levels, affect, and non-judgment. Psychopharmacology 237(3):773\u2013785. https:\/\/doi.org\/10.1007\/s00213-019-05414-w","journal-title":"Psychopharmacology"},{"issue":"9","key":"6517_CR238","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00213-019-05236-w","volume":"236","author":"MV Uthaug","year":"2019","unstructured":"Uthaug MV, Lancelotta R, van Oorsouw K, Kuypers KPC, Mason N, Rak J, \u0160ul\u00e1kov\u00e1 A, Jurok R, Mary\u0161ka M, Kucha\u0159 M, P\u00e1len\u00ed\u010dek T, Riba J, Ramaekers JG (2019) A single inhalation of vapor from dried toad secretion containing 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology 236(9):2653\u20132666. https:\/\/doi.org\/10.1007\/s00213-019-05236-w","journal-title":"Psychopharmacology"},{"key":"6517_CR239","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yebeh.2017.11.003","volume":"80","author":"RR van Koert","year":"2018","unstructured":"van Koert RR, Bauer PR, Schuitema I, Sander JW, Visser GH (2018) Caffeine and seizures: A systematic review and quantitative analysis. Epilepsy Behav 80:37\u201347. https:\/\/doi.org\/10.1016\/j.yebeh.2017.11.003","journal-title":"Epilepsy Behav"},{"key":"6517_CR240","doi-asserted-by":"publisher","unstructured":"Vilella, L., Lacuey, N., Hampson, J. P., Rani, M. R. S., Loparo, K., Sainju, R. K., Friedman, D., Nei, M., Strohl, K., Allen, L., Scott, C., Gehlbach, B. K., Zonjy, B., Hupp, N. J., Zaremba, A., Shafiabadi, N., Zhao, X., Reick-Mitrisin, V., Schuele, S., \u2026 Lhatoo, S. D. (2019). Incidence, recurrence, and risk factors for peri-ictal central apnea and sudden unexpected death in epilepsy. Frontiers in Neurology, 10, 166. https:\/\/doi.org\/10.3389\/fneur.2019.00166","DOI":"10.3389\/fneur.2019.00166"},{"key":"6517_CR241","doi-asserted-by":"publisher","unstructured":"Vinti V, Dell\u2019Isola GB, Tascini G, Mencaroni E, Cara GD, Striano P, Verrotti A (2021) Temporal lobe epilepsy and psychiatric comorbidity.\u00a0Front Neurol\u00a012:775781. https:\/\/doi.org\/10.3389\/fneur.2021.775781","DOI":"10.3389\/fneur.2021.775781"},{"key":"6517_CR242","doi-asserted-by":"publisher","first-page":"675768","DOI":"10.3389\/fnins.2021.675768","volume":"15","author":"PJ Vis","year":"2021","unstructured":"Vis PJ, Goudriaan AE, ter Meulen BC, Blom JD (2021) On perception and consciousness in HPPD: A systematic review. Front Neurosci 15:675768. https:\/\/doi.org\/10.3389\/fnins.2021.675768","journal-title":"Front Neurosci"},{"issue":"5","key":"6517_CR243","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/0269881117691569","volume":"31","author":"P Vizeli","year":"2017","unstructured":"Vizeli P, Liechti ME (2017) Safety pharmacology of acute MDMA administration in healthy subjects. J Psychopharmacol 31(5):576\u2013588. https:\/\/doi.org\/10.1177\/0269881117691569","journal-title":"J Psychopharmacol"},{"key":"6517_CR244","doi-asserted-by":"publisher","unstructured":"Vogt, S. B., Ley, L., Erne, L., Straumann, I., Becker, A. M., Klaiber, A., Holze, F., Vandersmissen, A., Mueller, L., Duthaler, U., Rudin, D., Luethi, D., Varghese, N., Eckert, A., & Liechti, M. E. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational Psychiatry, 13(1), Article 1. https:\/\/doi.org\/10.1038\/s41398-023-02477-4","DOI":"10.1038\/s41398-023-02477-4"},{"issue":"1","key":"6517_CR245","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0304-3940(92)90485-P","volume":"138","author":"Y Wada","year":"1992","unstructured":"Wada Y, Hasegawa H, Nakamura M, Yamaguchi N (1992) Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N, N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci Lett 138(1):115\u2013118. https:\/\/doi.org\/10.1016\/0304-3940(92)90485-P","journal-title":"Neurosci Lett"},{"issue":"2","key":"6517_CR246","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/jnnp-2012-303520","volume":"85","author":"C Warren-Gash","year":"2014","unstructured":"Warren-Gash C, Zeman A (2014) Is there anything distinctive about epileptic d\u00e9j\u00e0 vu? J Neurol Neurosurg Psychiatry 85(2):143\u2013147. https:\/\/doi.org\/10.1136\/jnnp-2012-303520","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"6517_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-8741(94)90051-5","volume":"41","author":"AT Weil","year":"1994","unstructured":"Weil AT, Davis W (1994) Bufo alvarius: A potent hallucinogen of animal origin. J Ethnopharmacol 41(1\u20132):1\u20138. https:\/\/doi.org\/10.1016\/0378-8741(94)90051-5","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"6517_CR248","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0091-3057(99)00178-1","volume":"65","author":"JC Winter","year":"2000","unstructured":"Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA (2000) The paradox of 5-methoxy-N, N-dimethyltryptamine. Pharmacol Biochem Behav 65(1):75\u201382. https:\/\/doi.org\/10.1016\/S0091-3057(99)00178-1","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"6517_CR249","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1176\/jnp.7.3.352","volume":"7","author":"GB Young","year":"1995","unstructured":"Young GB, Chandarana PC, Blume WT, McLachlan RS, Mu\u00f1oz DG, Girvin JP (1995) Mesial temporal lobe seizures presenting as anxiety disorders. J Neuropsychiatry Clin Neurosci 7(3):352\u2013357. https:\/\/doi.org\/10.1176\/jnp.7.3.352","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"6517_CR250","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnins.2020.00078","volume":"14","author":"JB Zawilska","year":"2020","unstructured":"Zawilska JB, Kacela M, Adamowicz P (2020) NBOMes\u2013Highly potent and toxic alternatives of LSD. Front Neurosci 14:78. https:\/\/doi.org\/10.3389\/fnins.2020.00078","journal-title":"Front Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06517-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:41:57Z","timestamp":1751517717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06517-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":250,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6517"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06517-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HMD and MS have no conflicts of interest. CDN is a co-founder and board member of 2A Biosciences, and has a Sponsored Research Agreement with 2A Biosciences. CDN is an advisor to Palo Santo. OS is a founder of Eudelics AB. RCH is a scientific advisor to Usona Institute, Synthesis Institute, Mydecine, Maya Health, Osmind, Entheos Labs, Beckley Psychtech, TRYP therapeutics, Journey Collab and Journey Space. PSH has been in paid advisory relationships with the following organizations regarding the development of psychedelics and related compounds: Bright Minds Biosciences Ltd., Eleusis Benefit Corporation, Journey Colab Corporation, Reset Pharmaceuticals Inc., and Silo Pharma. PSH has received research funding from the NIH and Heffter Research Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}